Of interest, 25 (72%) RA patients in the discovery cohort and 22 (42%) RA patient in the validation cohort were positive for HE4, but did not have ILD, suggesting other RA-related factors may influenced the levels of HE4. The gene discussed is WFDC2; the disease is interstitial lung disease.